Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study

MONDAY, May 12, 2025 — A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy.

The study — published May 11 in the New England Journal of...